11 July 2024
DR. MARTENS PLC
RESULT OF ANNUAL GENERAL MEETING
11 JULY 2024
The Company announces the results of voting at its Annual General Meeting held earlier today and confirms that all resolutions were duly passed on a poll with majorities as set out below.
Resolutions 1 to 16 were proposed as Ordinary Resolutions and resolutions 17 to 20 as Special Resolutions.
| Resolution
| Votes (note 1)
| %
| Votes Against (note 1)
| %
| Votes
| Votes Withheld (note 2) | % Voting Capital Instructed | |
| 01 | Receive the 2024 Annual Report and Accounts | 789,653,948 | 99.87% | 1,016,107 | 0.13% | 790,670,055 | 389,119 | 82.18 |
| 02 | Approve the Directors' Remuneration Report | 784,551,256 | 99.18% | 6,479,754 | 0.82% | 791,031,010 | 28,164 | 82.22 |
| 03 | Approve the Remuneration Policy | 784,540,438 | 99.18% | 6,484,634 | 0.82% | 791,025,072 | 34,102 | 82.22 |
| 04 | Approve the Final Dividend | 790,899,254 | 99.98% | 138,398 | 0.02% | 791,037,652 | 21,522 | 82.22 |
| 05 | Elect Giles Wilson | 790,575,687 | 99.94% | 472,252 | 0.06% | 791,047,939 | 11,235 | 82.22 |
| 06 | Re-elect Paul Mason | 739,380,746 | 98.45% | 11,649,105 | 1.55% | 751,029,851 | 40,029,322 | 78.06 |
| 07 | Re-elect Kenny Wilson | 782,546,350 | 99.38% | 4,857,639 | 0.62% | 787,403,989 | 3,655,185 | 81.84 |
| 08 | Re-elect Andrew Harrison | 784,035,245 | 99.11% | 7,011,325 | 0.89% | 791,046,586 | 12,587 | 82.22 |
| 09 | Re-elect Ian Rogers | 784,033,188 | 99.11% | 7,013,122 | 0.89% | 791,046,586 | 12,587 | 82.22 |
| 10 | Re-elect Lynne Weedall | 782,969,980 | 98.98% | 8,079,606 | 1.02% | 791,049,586 | 9,587 | 82.22 |
| 11 | Re-elect Robyn Perriss | 783,169,527 | 99.00% | 7,880,059 | 1.00% | 791,049,586 | 9,587 | 82.22 |
| 12 | Re-elect Tara Alhadeff | 775,890,657 | 98.53% | 11,583,929 | 1.47% | 787,474,586 | 3,584,587 | 81.85 |
| 13 | Re-appoint PricewaterhouseCoopers LLP as auditor | 790,431,574 | 99.92% | 619,491 | 0.08% | 791,051,065 | 8,109 | 82.22 |
| 14 | Authorise the Audit & Risk Committee to determine the Auditor's remuneration | 790,886,095 | 99.98% | 160,465 | 0.02% | 791,046,560 | 12,614 | 82.22 |
| 15 | Authorise the Company and its subsidiaries to make political donations | 782,418,912 | 99.36% | 5,046,388 | 0.64% | 787,465,300 | 3,593,874 | 81.85 |
| 16 | Authorise allotment of shares | 781,095,005 | 99.30% | 5,488,607 | 0.70% | 786,583,612 | 4,475,562 | 81.76 |
| 17 | Authorise general disapplication of pre-emption rights* | 744,775,869 | 94.58% | 42,685,045 | 5.42% | 787,460,914 | 3,598,260 | 81.85 |
| 18 | Authorise additional disapplication of pre-emption rights* | 743,752,064 | 94.45% | 43,708,850 | 5.55% | 787,460,914 | 3,598,260 | 81.85 |
| 19 | Authorise purchase of own shares* | 772,052,557 | 97.61% | 18,934,341 | 2.39% | 790,986,898 | 72,276 | 82.22 |
| 20 | Authorise calling of general meetings on 14 days' notice* | 788,373,014 | 99.66% | 2,680,102 | 0.34% | 791,053,116 | 6,058 | 82.22 |
*Special Resolution
The votes of independent shareholders on the resolutions concerning the election or re-election of the Independent Non-Executive Directors are set out below:
| Resolution
| Votes
| %
| Votes Against
| %
| Votes
| Votes Withheld
| % Independent Capital Instructed | |
| 08 | Re-elect Andrew Harrison | 414,092,821 | 98.34% | 7,011,325 | 1.66% | 421,104,146 | 12,587 | 71.12% |
| 09 | Re-elect Ian Rogers | 414,091,024 | 98.33% | 7,013,122 | 1.67% | 421,104,146 | 12,587 | 71.12% |
| 10 | Re-elect Lynne Weedall | 413,027,540 | 98.08% | 8,079,606 | 1.92% | 421,107,146 | 9,587 | 71.13% |
| 11 | Re-elect Robyn Perriss | 413,227,087 | 98.13% | 7,880,059 | 1.87% | 421,107,146 | 9,587 | 71.13% |
Notes:
1. Votes "For" and "Against" are expressed as a percentage of votes received.
2. A "Vote withheld" is not a vote in law and is not counted in the calculation of the votes "For" or "Against" a resolution.
3. As at 6.30pm on 9 July 2024 the Company had a total of 962,080,090 ordinary shares with voting rights in issue. The total independent voting capital, used to calculate the votes of independent shareholders on resolutions 8 to 11, was 592,062,882.
4. In accordance with Listing Rule 9.6.2R, copies of the resolutions passed as special business will shortly be available for inspection on the National Storage Mechanism at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
Enquiries
Company Secretariat
Paul Rolling, Assistant Company Secretary +44 7584 243562
Investors and analysts
Bethany Barnes, Director of Investor Relations +44 7825 187465
Media
Gill Hammond, Director of Communications +44 7384 214248
H/Advisors Maitland +44 20 7379 5151
Katharine Spence +44 7384 535739
About Dr. Martens
Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Produced originally for workers looking for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical movements. Dr. Martens has since transcended its working-class roots while still celebrating its proud heritage and, six decades later, "Docs" or "DM's" are worn by people around the world who use them as a symbol of empowerment and their own individual attitude. The Company is a constituent of the FTSE 250 index.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.